Adapt Pharma to offer all U.S. high schools a free NARCAN® Nasal Spray and fund school-based opioid overdose education
January 25, 2016
Dublin, Ireland – January 25, 2016 – Adapt Pharma, Limited (“Adapt Pharma”) today announced two national programs at the Clinton Health Matters Initiative Activation Summit to assist in efforts to address the growing risk of opioid overdose among American high-school students. First, Adapt Pharma will offer a free carton of NARCAN® (naloxone hydrochloride) Nasal Spray to all high schools in the United States through the state departments of education. This program will collaborate with the Clinton Health Matters Initiative, an initiative of the Clinton Foundation, as part of its work to scale naloxone access efforts nationally.
In addition, Adapt Pharma has provided a grant to the National Association of School Nurses (NASN) to support their educational efforts concerning opioid overdose education materials. To learn more click here or call 844-4-NARCAN.
NARCAN Nasal Spray is the only FDA approved, ready-to-use, needle-free nasal spray version of naloxone hydrochloride, indicated for the emergency treatment of opioid overdose. It is not a substitute for emergency medical care. See below for indication and important safety information. For multimedia content, please visithttp://inr.synapticdigital.com/adaptpharma/NARCAN/.
“We understand the crucial role schools can play to change the course of the opioid overdose epidemic by working with students and families. We also want every high school in the country to be prepared for an opioid emergency by having access to a carton of NARCAN Nasal Spray at no cost,” said Seamus Mulligan, Chairman and CEO of Adapt Pharma. “We look forward to working with our partners to implement these initiatives which build on the significant progress being made by legislators and community groups.”
“We are pleased to encourage public-private collaborations expanding access to naloxone,” said Rain Henderson, CEO of the Clinton Health Matters Initiative. “We are hopeful this effort will facilitate a dialogue amongst students, educators, health professionals, and families about the risks of opioid overdose and ensure naloxone is available in schools that decide to take steps to address opioid overdose emergencies.”
NASN President Beth Mattey noted that school nurses act as first responders in the school setting. “We educate our students, families, and school staff about prescription drug and substance abuse, and help families seek appropriate treatment and recovery options,” Mattey said. “Having access to naloxone can save lives and is often the first step toward recovery. We are taking a proactive approach to address the possibility of a drug overdose in school.”
Both programs build on Adapt Pharma’s recently announced initiative to facilitate affordable access to NARCAN Nasal Spray. Earlier this month, Adapt Pharma, in partnership with the National Association of Counties, National Governors Association, National League of Cities and United States Conference of Mayors, announced it will offer NARCAN Nasal Spray at a discounted Public Interest Price through the U.S. Communities Purchasing Alliance and Premier, Inc. to over 62,000 state and local government agencies. Click here for further details.